This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event November 17-23, 2021
In-Person November 17-19 | Virtual November 22-23Philadelphia, PA

Registration Options — Choose How You Attend

Register by August 20 and Save $500.

All Access Pass

All Access Pass Includes Access to:

  • The live, in-person event November 17-19 in Philadelphia, PA
  • Everything included in the virtual experience pass November 22-23
    • Recorded presentations from the in-person event, as well as daily live streaming content
    • Live and on-demand content for 30 days post-event
    • The full attendee list with video chat, instant message and meeting request functionalities

Register by August 20, 2021:

Life Sciences Companies: $2299

Solution Providers/Advisory & Audit Firms: $4299

Virtual Experience Pass

Virtual Experience Pass Includes Access to:

  • Recorded presentations from the in-person event, as well as daily live streaming content
  • Live and on-demand content for 30 days post-event
  • The full attendee list with video chat, instant message and meeting request functionalities

Register by August 20, 2021:

Life Sciences Companies: $1299

Solution Providers/Advisory & Audit Firms: $1799


Flexible Registration Policy

Register your team for an all access or virtual experience pass today knowing you're covered with our flexible registration policy. Any time up to 14 days before the event, you are welcome to substitute your all access pass for a digital experience pass, or vice versa (pending space availability). Simply contact us, and we will either charge you the difference for upgrading to all access or credit back the price for transferring to digital only.

Informa AllSecure is Informa’s approach to enhanced health and safety standards at our events following COVID-19